Skip to main content

MISSION
The Pershing Square Sohn Prize for Young Investigators in Cancer Research provides young New York area-based scientists the freedom to take risks and pursue their boldest research at a stage when traditional funding is lacking.  In the quest for cures, the Prize accelerates the collaboration between academia and industry.  Prize winners each receive $200,000 a year for up to three years.
 
KEY CRITERIA
Innovative research: Truly novel approaches in cancer research with strong scientific rationale. Early stage and bold proposals are encouraged and will receive special consideration. The research areas include but are not limited to technology development and basic biology.  The objective is to support projects that may be too innovative and speculative for traditional funding sources but still have a likelihood of producing important findings. It should be a unique project for scientists, who are encouraged to stretch their imagination into areas that can substantially change the area of research.

Scientific excellence: Scientific merit as determined by the Pershing Square Sohn Prize Scientific Advisory Council and the Prize Advisory Board.

Application to cancer: Proposals that articulate a clearly defined application to cancer will be favored. Goal is to advance research in new ways that will have an impact on understanding, diagnosis, prevention and/or treatment of cancer.
 
ELIGIBILITY
An MD, PhD, MD-PhD degree (or equivalent) is required. Applicants must have at least two (2) years of experience running their own laboratories but no more than eight (8) years of experience by the anticipated start date of the research project. Principal Investigators (PIs) must hold faculty appointments at academic research institutions in the New York area at the level of Assistant or Associate Professor (or equivalent). The New York area includes New York City, Long Island, and Northern and Central New Jersey.
 
An applicant who is not a U.S. citizen or permanent resident, by submitting an application for this funding, assures that his/her visa status will provide sufficient time to complete the project and grant term within the United States.  Investigators need not be specifically trained in cancer research; however, they should be working in an environment capable of conducting high quality, high impact cancer research.
 
2018 Prize Application Guidelines

We will begin accepting Letter of Intent applications for the 2018 Prize on Monday, October 2nd, 2017. 
If you have any questions regarding the Prize, please contact us at cbarrow@persq.org
Visit: www.psscra.org to learn more about the Alliance.